Westmoreland Center & Pharmacy is categorized under Outpatient Services in Dallas, TX and active since 2010.
Westmoreland Center & Pharmacy was established in 2010, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Outpatient Services business, which does work in the B2C market, and is classified as a Outpatient Services, under code number 6222100 by the NAICS.
If you are seeking more information, feel free to contact Mark Edery at the company’s single location by writing to 1350 North Westmoreland Road, Dallas, Texas TX 75211 or by phoning (214) 330-0036. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Westmoreland Center & Pharmacy |
| Contact Person: | Mark Edery |
| Address: | 1350 North Westmoreland Road, Dallas, Texas 75211 |
| Phone Number: | (214) 330-0036 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Outpatient Services |
| SIC Code: | 8093 |
| NAICS Code: | 6222100 |
| Share This Business: |
Westmoreland Center & Pharmacy was started in 2010 to provide professional Outpatient Services under the SIC code 8093 and NAICS code 6222100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Mark Edery for inquiries that concern Westmoreland Center & Pharmacy by calling the company number (214) 330-0036, as your correspondence is most welcome. Additionally, the physical location of the single location of Westmoreland Center & Pharmacy can be found at the coordinates 32.76361,-96.87233 as well as the street address 1350 North Westmoreland Road in Dallas, Texas 75211.
For its online presence, you may visit Westmoreland Center & Pharmacy’s website at and engage with its social media outlets through on Twitter and on Facebook.